KV

Kenvue Inc.

KVUEConsumer DefensiveNASDAQ

Household & Personal Products

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$15.12B
-2.1% YoY
Net Income
$1.47B
+42.7% YoY
EBITDA
$2.99B
+21.0% YoY
Free Cash Flow
$1.86B

Scan Results

Daily timeframe
6 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 8 RSI OverboughtRSI 71.5, above 70, stock may be overbought
Jul 7 RSI OverboughtRSI 70.6, above 70, stock may be overbought
About Kenvue Inc.

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. With a market capitalization of $36.44B, it sits in large-cap territory. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health.

Key stats
Market Cap$36.44B
P/E (TTM)22.60
Fwd P/E15.31
EPS$0.84
Beta0.44
52W Change-13.7%
Dividend Yield4.36%
ROE15.7%
Analysis

On the balance sheet, KVUE has $1.08B in cash with $8.80B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $1.86B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 15.7%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 7.1% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $14.95B (2022) to $15.12B (2025).

The relatively low beta of 0.44 suggests KVUE is a less volatile holding compared to the broader index. Kenvue Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. No single metric tells the full story. Reviewing KVUE's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Consumer Defensive stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms